SOPHiA GENETICS Expands Partnership With AstraZeneca

 The expanded partnership aims to leverage the global SOPHiA DDM™ platform and multimodal algorithmic capabilities to lead a new era of precision oncology by improving early patient identification and diagnosis, optimizing clinical development, and accelerating adoption of innovative medications along the care pathway

https://www.biospace.com/article/releases/sophia-genetics-expands-partnership-with-astrazeneca-to-include-multimodal-approaches-for-cancer-drug-development/